Pharmacocinétique des anticorps monoclonaux
Med Sci (Paris), 25 12 (2009) 1057-1062
Published online: 2009-12-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Pharmacological countermeasures for long-duration space missions: addressing cardiovascular challenges and advancing space-adapted healthcare
Audrey Derobertmasure, Li Shean Toh, Virginia E Wotring, Philip M Williams, Lucia Morbidelli, Julia C Stingl, Mathieu Vinken, Raghda Ramadan, Stephanie Chhun and Pierre BoutouyrieEuropean Journal of Pharmaceutical Sciences 209 107063 (2025)
https://doi.org/10.1016/j.ejps.2025.107063
Cancer du côlon : chimiothérapies
T. Lecomte, R. Chautard, E. Tournet and M. CauletEMC - Gastro-entérologie 40 (3) 1 (2023)
https://doi.org/10.1016/S1155-1968(22)44636-0
Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
Yara Al Ojaimi, Timothée Blin, Juliette Lamamy, et al.Pharmacology & Therapeutics 233 108022 (2022)
https://doi.org/10.1016/j.pharmthera.2021.108022
Variabilité pharmacocinétique des anticorps thérapeutiques
David Ternant and Stéphanie Chhunmédecine/sciences 35 (12) 1130 (2019)
https://doi.org/10.1051/medsci/2019210
Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics
A. Guillon, T. Sécher, L.A. Dailey, et al.International Journal of Pharmaceutics 536 (1) 116 (2018)
https://doi.org/10.1016/j.ijpharm.2017.11.049
A novel pharmacokinetic model based on the complex elimination of monoclonal antibodies for bevacizumab pharmacokinetic study in rabbits
Lei Wang, Shan Ji, Meizhen Li and Zeneng ChengInternational Immunopharmacology 31 39 (2016)
https://doi.org/10.1016/j.intimp.2015.12.016
Nebulization as a delivery method for mAbs in respiratory diseases
Renaud Respaud, Laurent Vecellio, Patrice Diot and Nathalie Heuzé-Vourc’hExpert Opinion on Drug Delivery 12 (6) 1027 (2015)
https://doi.org/10.1517/17425247.2015.999039
Médecine personnalisée en cancérologie digestive
N. Azzopardi, D. Ternant and G. PaintaudMédecine personnalisée en cancérologie digestive 275 (2013)
https://doi.org/10.1007/978-2-8178-0527-6_19
Are Hepatic Impairment Studies Necessary for Therapeutic Proteins?
Jun Yang, Stacy Shord, Hong Zhao, Yuxin Men and Atiqur RahmanClinical Therapeutics 35 (9) 1444 (2013)
https://doi.org/10.1016/j.clinthera.2013.06.010
Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety
Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.Therapies 67 (4) 329 (2012)
https://doi.org/10.2515/therapie/2012046
Anticorps monoclonaux à usage thérapeutique : spécificités du développement clinique, évaluation par les agences, suivi de la tolérance à long terme
Gilles Paintaud, Marine Diviné, Philippe Lechat, et al.Therapies 67 (4) 319 (2012)
https://doi.org/10.2515/therapie/2012043